$HTLD
HEARTLAND EXPRESS INC

2021 Q1 Form 10-Q Financial Statement

#000079923321000028 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $152.4M $166.3M
YoY Change -8.36% 19.18%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $105.9M $115.2M
YoY Change -8.07% 21.14%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $26.98M $26.76M
YoY Change 0.83% 19.2%
% of Gross Profit
Operating Expenses $138.3M $148.8M
YoY Change -7.06% 21.47%
Operating Profit $18.28M $17.33M
YoY Change 5.5% -16.87%
Interest Expense $100.0K $400.0K
YoY Change -75.0% -63.64%
% of Operating Profit 0.55% 2.31%
Other Income/Expense, Net
YoY Change
Pretax Income $18.42M $17.70M
YoY Change 4.03% -19.49%
Income Tax $4.683M $4.465M
% Of Pretax Income 25.43% 25.22%
Net Earnings $13.73M $13.24M
YoY Change 3.75% -23.56%
Net Earnings / Revenue 9.01% 7.96%
Basic Earnings Per Share $0.17 $0.16
Diluted Earnings Per Share $0.17 $0.16
COMMON SHARES
Basic Shares Outstanding 80.15M shares 81.87M shares
Diluted Shares Outstanding 80.21M shares 81.95M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $148.2M $64.20M
YoY Change 130.84% -63.58%
Cash & Equivalents $148.2M $64.18M
Short-Term Investments
Other Short-Term Assets $9.129M $11.00M
YoY Change -16.98% -16.51%
Inventory
Prepaid Expenses
Receivables $60.57M $62.85M
Other Receivables $0.00 $3.200M
Total Short-Term Assets $226.7M $149.3M
YoY Change 51.86% -41.07%
LONG-TERM ASSETS
Property, Plant & Equipment $512.8M $545.7M
YoY Change -6.03% 33.02%
Goodwill $168.3M $168.3M
YoY Change 0.0% 27.1%
Intangibles $24.15M $26.54M
YoY Change -9.01% 91.03%
Long-Term Investments
YoY Change
Other Assets $17.48M $18.18M
YoY Change -3.88% -0.8%
Total Long-Term Assets $722.8M $764.0M
YoY Change -5.4% 31.81%
TOTAL ASSETS
Total Short-Term Assets $226.7M $149.3M
Total Long-Term Assets $722.8M $764.0M
Total Assets $949.4M $913.3M
YoY Change 3.96% 9.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.00M $18.10M
YoY Change -6.08% 9.04%
Accrued Expenses $60.10M $53.60M
YoY Change 12.13% -3.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $84.06M $71.72M
YoY Change 17.2% -2.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $50.50M $56.40M
YoY Change -10.46% 5.62%
Total Long-Term Liabilities $142.9M $156.9M
YoY Change -8.88% 23.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $84.06M $71.72M
Total Long-Term Liabilities $142.9M $156.9M
Total Liabilities $227.0M $228.6M
YoY Change -0.7% 13.67%
SHAREHOLDERS EQUITY
Retained Earnings $903.1M $838.3M
YoY Change 7.73% 8.03%
Common Stock $5.383M $5.339M
YoY Change 0.82% 23.27%
Preferred Stock
YoY Change
Treasury Stock (at cost) $186.1M $158.9M
YoY Change 17.08% 7.06%
Treasury Stock Shares 10.78M shares 9.344M shares
Shareholders Equity $722.4M $684.7M
YoY Change
Total Liabilities & Shareholders Equity $949.4M $913.3M
YoY Change 3.96% 9.65%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $13.73M $13.24M
YoY Change 3.75% -23.56%
Depreciation, Depletion And Amortization $26.98M $26.76M
YoY Change 0.83% 19.2%
Cash From Operating Activities $35.43M $40.06M
YoY Change -11.55% 11.99%
INVESTING ACTIVITIES
Capital Expenditures $9.750M $42.09M
YoY Change -76.84% 23.04%
Acquisitions
YoY Change
Other Investing Activities -$78.00K -$51.00K
YoY Change 52.94% 1175.0%
Cash From Investing Activities $15.48M -$39.63M
YoY Change -139.06% 93.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $15.02M $12.28M
YoY Change 22.35%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$16.72M -$14.15M
YoY Change 18.18% 709.67%
NET CHANGE
Cash From Operating Activities $35.43M $40.06M
Cash From Investing Activities $15.48M -$39.63M
Cash From Financing Activities -$16.72M -$14.15M
Net Change In Cash $34.20M -$13.72M
YoY Change -349.23% -201.11%
FREE CASH FLOW
Cash From Operating Activities $35.43M $40.06M
Capital Expenditures $9.750M $42.09M
Free Cash Flow $25.68M -$2.035M
YoY Change -1362.01% -230.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
HEARTLAND EXPRESS INC
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000799233
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79905675 shares
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1100000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1100000 USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
395000000 shares
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
395000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90689000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90689000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79905000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80653000 shares
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
10784000 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
10036000 shares
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
16090000 USD
CY2021Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 USD
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
200000 USD
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Entity File Number
EntityFileNumber
0-15087
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
HEARTLAND EXPRESS INC
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
93-0926999
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
901 Heartland Way,
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
North Liberty,
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IA
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
52317
CY2021Q1 dei City Area Code
CityAreaCode
319
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
626-3600
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2021Q1 dei Trading Symbol
TradingSymbol
HTLD
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79905675 shares
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148212000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113852000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60568000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
55577000 USD
CY2021Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
8758000 USD
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
8241000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
9129000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
15342000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
226667000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
193012000 USD
CY2021Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
83361000 USD
CY2020Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
77525000 USD
CY2021Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
87713000 USD
CY2020Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
86712000 USD
CY2021Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
5034000 USD
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4807000 USD
CY2021Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
14551000 USD
CY2020Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
14380000 USD
CY2021Q1 htld Revenue Equipment
RevenueEquipment
562501000 USD
CY2020Q4 htld Revenue Equipment
RevenueEquipment
590153000 USD
CY2021Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
6908000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
240080000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
512833000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
539280000 USD
CY2020Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
5783000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
760068000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
779360000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
247235000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
168295000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
168295000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24148000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24746000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8164000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17478000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17679000 USD
CY2021Q1 us-gaap Assets
Assets
949421000 USD
CY2020Q4 us-gaap Assets
Assets
951176000 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16954000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
19053000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12751000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25607000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22422000 USD
CY2021Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
15482000 USD
CY2020Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
15837000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
18557000 USD
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6960000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1475000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
84056000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
71042000 USD
CY2021Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5564000 USD
CY2020Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5801000 USD
CY2021Q1 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
92450000 USD
CY2020Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
104004000 USD
CY2021Q1 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
44934000 USD
CY2020Q4 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
45995000 USD
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
142948000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
155800000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
907000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
907000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4476000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4330000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
903105000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
890970000 USD
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
186071000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
171873000 USD
CY2021Q1 htld Stockholders Equity Attributable To Parent2
StockholdersEquityAttributableToParent2
722417000 USD
CY2020Q4 htld Stockholders Equity Attributable To Parent2
StockholdersEquityAttributableToParent2
724334000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
949421000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
951176000 USD
CY2021Q1 us-gaap Revenues
Revenues
152402000 USD
CY2020Q1 us-gaap Revenues
Revenues
166318000 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
64782000 USD
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
70254000 USD
CY2021Q1 htld Rent And Purchased Transportation
RentAndPurchasedTransportation
964000 USD
CY2020Q1 htld Rent And Purchased Transportation
RentAndPurchasedTransportation
1608000 USD
CY2021Q1 us-gaap Fuel Costs
FuelCosts
24157000 USD
CY2020Q1 us-gaap Fuel Costs
FuelCosts
25941000 USD
CY2021Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5688000 USD
CY2020Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6800000 USD
CY2021Q1 us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
3621000 USD
CY2020Q1 us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
3842000 USD
CY2021Q1 us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
5439000 USD
CY2020Q1 us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
5354000 USD
CY2021Q1 us-gaap Direct Communications And Utilities Costs
DirectCommunicationsAndUtilitiesCosts
1226000 USD
CY2020Q1 us-gaap Direct Communications And Utilities Costs
DirectCommunicationsAndUtilitiesCosts
1421000 USD
CY2021Q1 htld Depreciationandamortizationexcludingdepreciationoncommunicationequipment
Depreciationandamortizationexcludingdepreciationoncommunicationequipment
26926000 USD
CY2020Q1 htld Depreciationandamortizationexcludingdepreciationoncommunicationequipment
Depreciationandamortizationexcludingdepreciationoncommunicationequipment
26634000 USD
CY2021Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5552000 USD
CY2020Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6909000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4232000 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-229000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
134123000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
148992000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
18279000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17326000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
138000 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
377000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18417000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17703000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4683000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4465000 USD
CY2021Q1 htld Net Income
NetIncome
13734000 USD
CY2020Q1 htld Net Income
NetIncome
13238000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13734000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13238000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80152000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81870000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80206000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81945000 shares
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
724334000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
13734000 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1599000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
14537000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
485000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
722417000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
684659000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
13238000 USD
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1628000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12278000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
697000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
684688000 USD
CY2021Q1 htld Net Income
NetIncome
13734000 USD
CY2020Q1 htld Net Income
NetIncome
13238000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26983000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26761000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
3390000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-7541000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
581000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
936000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4232000 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-229000 USD
CY2021Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
4991000 USD
CY2020Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
6096000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4053000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-470000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2554000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-55000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5248000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2967000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35432000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40057000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
25152000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2409000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9750000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42092000 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-78000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-51000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15480000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39632000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1599000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1628000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
96000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
239000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15022000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12278000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16717000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14145000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
34195000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13720000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131140000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96076000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165335000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82356000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2825000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-109000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6726000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8554000 USD
CY2021Q1 htld Soldrevenueequipmentinothercurrentassets
Soldrevenueequipmentinothercurrentassets
212000 USD
CY2020Q1 htld Soldrevenueequipmentinothercurrentassets
Soldrevenueequipmentinothercurrentassets
2000000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148212000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64183000 USD
CY2021Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
1033000 USD
CY2020Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
1533000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
16090000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
16640000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165335000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82356000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segments
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1300000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1300000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3500000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Revenues
Revenues
152400000 USD
CY2020Q1 us-gaap Revenues
Revenues
166300000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3100000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17100000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
16100000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17300000 USD
CY2020Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
1100000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
16200000 USD
CY2021Q1 htld Amortization Period Of Tires
AmortizationPeriodOfTires
two years
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
200000 USD
CY2020 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
3400000 USD
CY2021Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80152000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
41200000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17052000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24148000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 htld Net Income Loss Eps
NetIncomeLossEPS
13734000 USD
CY2021Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
54000 shares
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13734000 USD
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80206000 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2020Q1 htld Net Income Loss Eps
NetIncomeLossEPS
13238000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81870000 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2020Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
75000 shares
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13238000 USD
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81945000 shares
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2021Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
4700000 shares
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1600000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1600000 USD
CY2011Q3 htld Restricted Stock Shares Authorized
RestrictedStockSharesAuthorized
900000 shares
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
600000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
800000 shares
CY2021Q1 htld Treasury Stock Value Acquired
TreasuryStockValueAcquired
-14500000 USD
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
700000 shares
CY2020Q1 htld Treasury Stock Value Acquired
TreasuryStockValueAcquired
-12300000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
900000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
500000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y9M18D
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
53700 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.95
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
52100 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.55
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
59700 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.29
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
19300 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.69
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
25300 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
19.78
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
60200 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.84
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
38000.0 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
20.86
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
500 shares
CY2021Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
88500000 USD
CY2021Q1 htld Allowable Amount For Issuanceof Lettersof Credit
AllowableAmountForIssuanceofLettersofCredit
30000000.0 USD
CY2021Q1 htld Debt Instrument Covenant Leverage Ratio
DebtInstrumentCovenantLeverageRatio
2
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
19.32
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
73800 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.66
CY2013Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
250000000.0 USD
CY2016Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
175000000.0 USD
CY2021Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
100000000.0 USD
CY2013Q4 htld Allowable Amount For Issuanceof Lettersof Credit
AllowableAmountForIssuanceofLettersofCredit
20000000.0 USD
CY2021Q1 htld Debt Covenant Minimum Net Income Requirement
DebtCovenantMinimumNetIncomeRequirement
1.00 USD
CY2021Q1 htld Debt Covenant Minimum Tangible Net Worth
DebtCovenantMinimumTangibleNetWorth
250000000.0 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
11500000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.254
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.252
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4700000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4900000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3700000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3900000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
200000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
100000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
800000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
900000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4937000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
175000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
179000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
213000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4720000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
121300000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31

Files In Submission

Name View Source Status
0000799233-21-000028-index-headers.html Edgar Link pending
0000799233-21-000028-index.html Edgar Link pending
0000799233-21-000028.txt Edgar Link pending
0000799233-21-000028-xbrl.zip Edgar Link pending
exhibit3112021q1.htm Edgar Link pending
exhibit3122021q1.htm Edgar Link pending
exhibit3212021q1.htm Edgar Link pending
exhibit3222021q1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
htld-20210331.htm Edgar Link pending
htld-20210331.xsd Edgar Link pending
htld-20210331_cal.xml Edgar Link unprocessable
htld-20210331_def.xml Edgar Link unprocessable
htld-20210331_htm.xml Edgar Link completed
htld-20210331_lab.xml Edgar Link unprocessable
htld-20210331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending